Effectively nursing patients receiving aromatase inhibitor therapy.

@article{Wengstrm2008EffectivelyNP,
  title={Effectively nursing patients receiving aromatase inhibitor therapy.},
  author={Yvonne Wengstr{\"o}m},
  journal={Breast},
  year={2008},
  volume={17 3},
  pages={227-38}
}
Inhibiting estrogen production is a common means of preventing breast cancer recurrence. The aromatase inhibitors (AIs) are becoming the preferred treatment over tamoxifen as adjuvant therapy for postmenopausal women with hormone-sensitive early breast cancer. Like all adjuvant therapies, AIs have adverse events (AEs) associated with their use, many of… CONTINUE READING